Antineoplastics/immunotherapiesLack of efficacy and GI toxicity: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1927卷 / 1期

关键词：

D O I：

10.1007/s40278-022-24819-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：83 / 83

相关论文

共 50 条

[1] Antineoplastics/bevacizumabLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2022, 1913 (1) : 73 - 73
[2] Antineoplastics/epirubicinLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2022, 1927 (1) : 78 - 78
[3] Antineoplastics and methylprednisoloneLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2023, 1938 (1) : 181 - 181
[4] Antineoplastics/nivolumab/osimertinibLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2022, 1922 (1) : 88 - 88
[5] FluorouracilNeutropenia, GI toxicity and lethal toxicity: 3 case reports
[J]. Reactions Weekly, 2020, 1799 (1) : 188 - 188
[6] Antineoplastics/folinic-acidLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2023, 1959 (1) : 94 - 94
[7] Antineoplastics/folinic acid/hydroxychloroquineLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2023, 1963 (1) : 83 - 83
[8] Antineoplastics/epirubicinLack of efficacy and Pneumocystis pneumonia: 3 case reports
[J]. Reactions Weekly, 2022, 1900 (1) : 59 - 59
[9] Antineoplastics/immunosuppressantsLack of efficacy: 4 case reports
[J]. Reactions Weekly, 2022, 1928 (1) : 60 - 60
[10] Antineoplastics/denosumabLack of efficacy: 2 case reports
[J]. Reactions Weekly, 2022, 1934 (1) : 62 - 62

← 1 2 3 4 5 →